Inventor · disambiguated record
Cuixian Liu
Also filed as: LIU CUIXIAN
55 granted patents·9 pending applications·603 citations·filing 2003–2023
99Inventor score
Files withFORMA THERAPEUTICS INC34VALO HEALTH INC11ACHILLION PHARMACEUTICALS INC8VALO EARLY DISCOVERY INC6PHADKE AVINASH2
Top patents by PatentIndex Score
64 records- 0199US10829461B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 10, 2020·15 cites·12 claims
- 0299US10829462B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 10, 2020·15 cites·17 claims
- 0399US10377726B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·22 cites·10 claims
- 0499US10112915B23-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·41 cites·31 claims
- 0598US11279681B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2020·Granted Mar 22, 2022·6 cites·20 claims
- 0698US10822316B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 3, 2020·10 cites·15 claims
- 0798US10494354B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·17 cites·17 claims
- 0898US10494353B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·17 cites·12 claims
- 0998US10472337B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2019·17 cites·12 claims
- 1098US10428031B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 1, 2019·15 cites·20 claims
- 1198US10421731B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·15 cites·19 claims
- 1298US10421732B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·16 cites·13 claims
- 1398US10414738B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·16 cites·20 claims
- 1498US10239845B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Mar 26, 2019·25 cites·42 claims
- 1598US10214501B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·20 cites·38 claims
- 1698US10214500B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·20 cites·35 claims
- 1797US10988450B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 27, 2021·6 cites·14 claims
- 1897US10513501B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·11 cites·20 claims
- 1997US10494352B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·12 cites·20 claims
- 2097US10494351B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·12 cites·20 claims
- 2197US10464910B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·12 cites·15 claims
- 2297US10464909B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·12 cites·17 claims
- 2397US10457652B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 29, 2019·12 cites·18 claims
- 2497US10450283B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 22, 2019·14 cites·16 claims
- 2597US10450284B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 22, 2019·14 cites·13 claims
- 2697US10442776B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 15, 2019·15 cites·18 claims
- 2794US10479772B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 19, 2019·6 cites·13 claims
- 2893US9745253B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Aug 29, 2017·10 cites·53 claims
- 2993US8088806B2Thiazole compounds and methods of useZHANG SUOMING·Filed 2006·Granted Jan 3, 2012·32 cites·13 claims
- 3092US11891365B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2021·Granted Feb 6, 2024·1 cites·23 claims
- 3192US7767706B2Substituted aryl acylthioureas and related compounds; inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2008·Granted Aug 3, 2010·23 cites·8 claims
- 3289US11274084B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2020·Granted Mar 15, 2022·1 cites·18 claims
- 3389US10538496B2Methods using HDAC11 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·3 cites·5 claims
- 3489US10508088B2Methods using HDAC11 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 17, 2019·3 cites·11 claims
- 3589US9133115B24-amino-4-oxobutanoyl peptides as inhibitors of viral replicationPHADKE AVINASH·Filed 2013·Granted Sep 15, 2015·10 cites·4 claims
- 3689US8614180B24-amino-4-oxobutanoyl peptides as inhibitors of viral replicationPHADKE AVINASH·Filed 2009·Granted Dec 24, 2013·14 cites·4 claims
- 3788US11247987B2Inhibiting ubiquitin specific peptidase 30FORMA THERAPEUTICS INC·Filed 2018·Granted Feb 15, 2022·3 cites·24 claims
- 3888US10266487B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 23, 2019·4 cites·16 claims
- 3987US11345672B2Methods using HDAC11 inhibitorsVALO HEALTH INC·Filed 2019·Granted May 31, 2022·2 cites·19 claims
- 4087US7365068B2Substituted aryl acylthioureas and related compounds; inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2005·Granted Apr 29, 2008·11 cites·19 claims
- 4186US7476686B2Substituted aryl thioureas and related compounds; inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2004·Granted Jan 13, 2009·23 cites·23 claims
- 4285US12264137B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2022·Granted Apr 1, 2025·0 cites·17 claims
- 4385US10988441B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 27, 2021·1 cites·20 claims
- 4485US10501424B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2019·1 cites·17 claims
- 4585US10029995B2[6,6] fused bicyclic HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·3 cites·39 claims
- 4685US7094807B2Substituted aryl thioureas and related compounds; inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2003·Granted Aug 22, 2006·20 cites·12 claims
- 4784US10508077B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Dec 17, 2019·2 cites·20 claims
- 4884US10370343B2[6,6] Fused bicyclic HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 6, 2019·2 cites·18 claims
- 4982US10829460B2[6,6] fused bicyclic HDAC8 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 10, 2020·1 cites·20 claims
- 5082US2023406830A1[6,6] fused bicyclic hdac8 inhibitorsVALO HEALTH INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Cuixian Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →